Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 08:38 am Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | STATE STREET CORP STT | 5,513,680 7.3% | -2,506,319 (-31.25%) | View |
| 2022-01-27 5:13 pm Unchanged | 13G | KARYOPHARM THERAPEUTICS INC KPTI | BlackRock Inc. BLK | 8,918,206 11.8% | 0 (Unchanged) | View |
| 2022-01-26 09:16 am Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | BlackRock Inc. BLK | 8,918,206 11.8% | 1,443,107 (+19.31%) | View |
| 2021-10-12 12:23 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | STATE STREET CORP STT | 8,019,999 10.62% | 2,680,140 (+50.19%) | View |
| 2021-02-17 3:12 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-16 4:41 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Palo Alto Investors LP | 5,267,652 7.16% | 672,651 (+14.64%) | View |
| 2021-02-16 4:35 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Kauffman Michael | 4,231,457 5.51% | 310,023 (+7.91%) | View |
| 2021-02-16 4:03 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Chione Ltd | 5,500,000 7.5% | -195,499 (-3.43%) | View |
| 2021-02-16 2:21 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Consonance Capital Management LP | 6,058,505 11% | -68,929 (-1.12%) | View |
| 2021-02-12 08:13 am Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Avoro Capital Advisors LLC | 0 0% | -5,900,000 (Position Closed) | View |
| 2021-02-11 3:09 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | STATE STREET CORP STT | 5,339,859 7.26% | 2,111,493 (+65.40%) | View |
| 2021-02-11 08:19 am Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,465,000 3.35% | -1,322,000 (-34.91%) | View |
| 2021-01-26 6:52 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | BlackRock Inc. BLK | 7,475,099 10.2% | 61,294 (+0.83%) | View |
| 2020-12-08 4:56 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | BlackRock Inc. BLK | 7,413,805 10.1% | 2,644,879 (+55.46%) | View |
| 2020-02-14 5:12 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Point72 Asset Management L.P. | 66,600 0.1% | -3,439,056 (-98.10%) | View |
| 2020-02-14 4:07 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Ridgeback Capital Investments L.P. | 0 0% | -3,945,200 (Position Closed) | View |
| 2020-02-14 3:31 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Chione Ltd | 5,695,499 9.1% | -1,935,768 (-25.37%) | View |
| 2020-02-14 3:07 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Palo Alto Investors LP | 4,595,001 7.32% | -90,351 (-1.93%) | View |
| 2020-02-14 1:34 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Consonance Capital Management LP | 6,127,434 9.76% | 1,317,356 (+27.39%) | View |
| 2020-02-14 10:23 am Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Avoro Capital Advisors LLC | 5,900,000 9.4% | 5,900,000 (New Position) | View |